However, in clinical patients, the genomic breakpoints in both BCR and ABL of CML cells are dispersed over intervals of 3.0 kb and ~150 kb, respectively. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.